Investors aiming for above-average returns often turn to the practice of stock picking. Skillful choices in individual stocks can be a catalyst for substantial wealth growth.
The price of Macrogenics Inc (NASDAQ: MGNX) closed at $3.41 in the last session, up 2.10% from day before closing price of $3.34. In other words, the price has increased by $2.10 from its previous closing price. On the day, 0.52 million shares were traded. MGNX stock price reached its highest trading level at $3.485 during the session, while it also had its lowest trading level at $3.245.
Ratios:
We take a closer look at MGNX’s different ratios to gain a better understanding of the stock. For the most recent quarter (mrq), Quick Ratio is recorded 3.69 and its Current Ratio is at 3.75. In the meantime, Its Debt-to-Equity ratio is 0.28 whereas as Long-Term Debt/Eq ratio is at 0.24.
Insider Transactions:
An investor can also benefit from insider trades by learning what management is thinking about the future direction of stock prices. A recent insider transaction in this stock occurred on Apr 04 ’24 when Peters Jeffrey Stuart sold 51,395 shares for $15.55 per share. The transaction valued at 799,148 led to the insider holds 0 shares of the business.
Peters Jeffrey Stuart sold 19,625 shares of MGNX for $421,938 on Mar 06 ’24. The Senior VP and General Counsel now owns 8,895 shares after completing the transaction at $21.50 per share. On Mar 04 ’24, another insider, Risser Eric Blasius, who serves as the Chief Operating Officer of the company, sold 41,159 shares for $19.76 each. As a result, the insider received 813,501 and left with 38,900 shares of the company.
Valuation Measures:
Investors should consider key stock statistics when deciding whether to invest or divest. In the wake of the recent closing price, MGNX now has a Market Capitalization of 214023200 and an Enterprise Value of 47760356. For the stock, the TTM Price-to-Sale (P/S) ratio is 1.51 while its Price-to-Book (P/B) ratio in mrq is 1.78. Its current Enterprise Value per Revenue stands at 0.338 whereas that against EBITDA is -0.479.
Stock Price History:
The Beta on a monthly basis for MGNX is 2.03, which has changed by -0.64124596 over the last 52 weeks, in comparison to a change of 0.27870452 over the same period for the S&P500. Over the past 52 weeks, MGNX has reached a high of $21.88, while it has fallen to a 52-week low of $2.95. The 50-Day Moving Average of the stock is -7.78%, while the 200-Day Moving Average is calculated to be -52.10%.
Shares Statistics:
According to the various share statistics, MGNX traded on average about 606.74K shares per day over the past 3-months and 464820 shares per day over the past 10 days. A total of 62.76M shares are outstanding, with a floating share count of 57.89M. Insiders hold about 7.77% of the company’s shares, while institutions hold 84.43% stake in the company. Shares short for MGNX as of 1732838400 were 5214021 with a Short Ratio of 8.59, compared to 1730332800 on 5457556. Therefore, it implies a Short% of Shares Outstanding of 5214021 and a Short% of Float of 10.190000000000001.
